The abstract is read at the publisher; the summary is JClub's.
In a Budd-Chiari syndrome patient serum study, dinotefuran (DIN) is linked to higher aspartate aminotransferase (AST), with a median total of 392.4 ng/L across 8 neonicotinoids.
- Why it matters: Neonicotinoids are commonly found in human blood, but their health relevance in people with impaired liver function—such as Budd-Chiari syndrome—has been unclear.
- What they did: Eight neonicotinoids were measured in Budd-Chiari syndrome serum, and generalized linear models with product terms tested associations with liver-injury and coagulation biomarkers, including effect modification by sex and hepatocellular carcinoma status.
- The result: DIN showed a significant positive association with AST (β=13.07, 95% CI: 0.66–25.48, p=0.040), while thiamethoxam (THIA) was significantly negatively associated with D-dimer and fibrinogen; sex and hepatocellular carcinoma status significantly modified several NNI–biomarker links.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.